See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Thomas Mavrakanas

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	39495569	0	Harel Z, Smyth B, Badve SV, et al. Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial. J Am Soc Nephrol. 2024 Nov 4. doi: 10.1681/ASN.0000000000000495.
	38939758	0	AlTurki A, Marafi M, Dawas A, et al. Meta-analysis evaluating apixaban in patients with atrial fibrillation and end-stage renal disease requiring dialysis. J Arrhythm. 2024 May 6;40(3):440-447. doi: 10.1002/joa3.13051. eCollection 2024 Jun.
	38744617	0	Wing SM, Mavrakanas TA, Harel Z. Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review. Semin Nephrol. 2024 May 14:151517. doi: 10.1016/j.semnephrol.2024.151517.
	38272779	0	Ades M, Simard C, Vanassche T, et al. Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease. Semin Nephrol. 2023 Nov;43(6):151484. doi: 10.1016/j.semnephrol.2023.151484. Epub 2024 Jan 24.
	38035566	0	Elenjickal EJ, Travlos CK, Marques P, et al. Anticoagulation in Patients with Chronic Kidney Disease. Am J Nephrol. 2024;55(2):146-164. doi: 10.1159/000535546. Epub 2023 Nov 30.
	37768893	0	Festa MC, Rasasingam S, Sharma A, et al. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis. Kidney360. 2023 Sep 1;4(9):e1245-e1256. doi: 10.34067/KID.0000000000000223. Epub 2023 Aug 1.
	37526953	0	Festa MC, Rasasingam S, Sharma A, et al. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease (CKD) Undergoing Percutaneous Coronary Intervention with a Drug Eluting Stent: A Meta-Analysis. Kidney360. 2023 Aug 1. doi: 10.34067/KID.0000000000000223.
	37059362	0	Mavrakanas TA. Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation. Kidney Int. 2023 Jun;103(6):1014-1017. doi: 10.1016/j.kint.2023.03.027. Epub 2023 Apr 12.
	36514740	0	Mavrakanas TA, Charytan DM. Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360. 2022 Aug 1;3(10):1769-1771. doi: 10.34067/KID.0003002022. eCollection 2022 Oct 27.
	35470213	0	Mavrakanas TA. Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis. Clin J Am Soc Nephrol. 2022 Apr 25. pii: CJN.03410322. doi: 10.2215/CJN.03410322.
	35378030	0	Mavrakanas TA. Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: COMMENTARY. Kidney360. 2021 Apr 9;2(9):1412-1414. doi: 10.34067/KID.0001372021. eCollection 2021 Sep 30.
	33470571	0	Barrelet I, Mavrakanas T, Carballo S. [Oral anticoagulation in chronic kidney disease]. Rev Med Suisse. 2021 Jan 20;17(722):142-145.
	32740218	0	Mavrakanas TA, Charytan DM, Winkelmayer WC. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 Sep;29(5):489-496. doi: 10.1097/MNH.0000000000000634.
	32444398	0	Mavrakanas TA, Garlo K, Charytan DM. Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1146-1154. doi: 10.2215/CJN.11650919. Epub 2020 May 22.
	32333946	0	Ashley J, McArthur E, Bota S, et al. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. Am J Kidney Dis. 2020 Sep;76(3):311-320. doi: 10.1053/j.ajkd.2020.02.446. Epub 2020 Apr 22.
	29731031	0	Mavrakanas TA, Sood MM. Direct Factor Xa Inhibitors for Long-term Stroke Prevention in Atrial Fibrillation: Could the Lower Dose Fit All? Can J Cardiol. 2018 May;34(5):690.e15. doi: 10.1016/j.cjca.2018.02.003. Epub 2018 Feb 7.
	26507303	0	Gariani K, Mavrakanas T, Combescure C, et al. Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies. Eur J Intern Med. 2016 Mar;28:52-8. doi: 10.1016/j.ejim.2015.10.001. Epub 2015 Oct 23.
	25658756	0	Mavrakanas TA, Samer C, Fontana P, et al. Direct oral anticoagulants: efficacy and safety in patient subgroups. Swiss Med Wkly. 2015 Feb 6;145:w14081. doi: 10.4414/smw.2015.14081. eCollection 2015.